Muna Therapeutics Announces Nature Medicine Publication Validating Microglial State Transitions as Key Drivers of Alzheimer's

Study leveraging Muna's MiND-MAP platform identifies critical tipping point in microglial response to amyloid and tau pathology Findings validate Muna's differentiated strategy targeting TREM2 signaling to boost neuroprotection COPENHAGEN, Denmark and BOSTON, June 4, 2026 /PRNewswire/ --...